Send me a link:

*Text messaging rates may apply.

 Dow Down 0.39% Nasdaq Down 0.60%

Geron Corporation (GERN)

-NasdaqGS
2.32 Down 0.08(3.33%) 11:36AM EDT - Nasdaq Real Time Price
Prev Close:2.41
Open:2.41
Bid:2.31 x 10200
Ask:2.32 x 4700
1y Target Est:4.13
Beta:2.49
Next Earnings Date:11-Aug-14GERN Earnings announcement
Day's Range:2.31 - 2.43
52wk Range:1.20 - 7.36
Volume:857,401
Avg Vol (3m):4,488,120
Market Cap:364.85M
P/E (ttm):N/A
EPS (ttm):-0.26
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GERNDown 3.33%364.85M
BMYDown 0.83%83.23B
GSKDown 1.18%114.82B
NVSUp 0.03%211.01B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):380.48
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.25
Quarterly EPS Est (Jun-14) :-0.06
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):-1.98

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Geron Corporation, a clinical stage biopharmaceutical company, develops a telomerase inhibitor, imetelstat, to treat hematologic myeloid malignancies. The company was founded in 1990 and is based in Menlo Park, California. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback